Existing user? Login

Drug delivery

Novel method could help develop new treatments that cross the blood–brain barrier

Researchers have developed a platform that allows them to study the opening and closing of the blood-brain barrier (BBB) in real-time.

The team says the method, which works with cultured cells, could help to design new treatments that can cross the BBB while preventing damage to healthy cells.

The system they have developed uses simultaneous electrical, optical and pressure-based measurements to provide real-time information on the effect of a microbubble and ultrasound technique to open the BBB.

This microbubble-based approach to surmounting the BBB is already being used in clinical trials. It works by injecting microbubbles into the bloodstream and then, by applying ultrasound, the blood-brain barrier can be opened at specific locations to deliver targeted treatment to the brain. But the researchers hope their platform will provide more detailed information on its biological effects.

“The treatment can be monitored externally by ‘listening’ to the re-radiated sound from the cavitation agents interacting with the ultrasound field,” explains researcher Miles Aron, who presented the work[1] at the Acoustics ’17 conference in Boston, Massachusetts.

“These acoustic emissions provide information regarding the energy of cavitation within the blood vessels and are already being used to adjust ultrasound parameters in real time to reduce the likelihood of damaging healthy cells during treatment.”

The researchers say their method, which works like a blood-brain barrier “on a chip”, could be used to screen cavitation agents, such as microbubbles, as well as therapeutics.

The team, based at the Institute of Biomedical Engineering at Oxford University, is currently using the platform to test new treatments for brain diseases and cancer.

“To bring these new techniques to the clinic, we will use our in vitro platform to guide our design and to choose the most promising approaches for animal studies and eventually clinical trials,” says Aron.

Citation: Electronicjuice DOI: 10.1211/PJ.2017.20203063

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

  • Paediatric Drug Handling

    Written for new pharmaceutical scientists, this book provides a background in paediatric pharmacy and a comprehensive introduction to children's medication.

  • Foundation in Pharmacy Practice

    A practical and succinct overview of the principal pharmacy practice topics, for new pharmacy students.

  • Non-medical Prescribing

    An essential new guide designed to ensure confident prescribing in specialist areas.

  • Obesity Epidemic and Its Management (The)

    The Obesity Epidemic and its Management explains the causes, dangers and treatments of obesity.


Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save

Supplementary images

  • cultured cells in petri dish

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.

купить провирон